Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.

by Katsuyuki Hotta, Katsuyuki Kiura, Yoshiro Fujiwara, Nagio Takigawa, Akiko Hisamoto, Eiki Ichihara, Masahiro Tabata, Mitsune Tanimoto
Published 2011-01-01

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.

by Isao Oze, Katsuyuki Hotta, Katsuyuki Kiura, Nobuaki Ochi, Nagio Takigawa, Yoshiro Fujiwara, Masahiro Tabata, Mitsune Tanimoto
Published 2009-01-01

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.

by Nobuaki Ochi, Katsuyuki Hotta, Nagio Takigawa, Isao Oze, Yoshiro Fujiwara, Eiki Ichihara, Akiko Hisamoto, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura
Published 2012-01-01

Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non...

by Katsuyuki Hotta, Yuka Kato, Natasha Leighl, Nagio Takigawa, Rabab Mohamed Gaafar, Hiroe Kayatani, Taizo Hirata, Kadoaki Ohashi, Toshio Kubo, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura
Published 2015-01-01

Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report

by Yoko Suzuki, Kohei Taniguchi, Minami Hatono, Yukiko Kajiwara, Yuko Abe, Kengo Kawada, Takahiro Tsukioki, Mariko Kochi, Keiko Nishiyama, Takayuki Iwamoto, Hirokuni Ikeda, Tadahiko Shien, Naruto Taira, Masahiro Tabata, Hiroyuki Yanai, Hiroyoshi Doihara
Published 2020-01-01